Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Type of study
Language
Publication year range
1.
World J Gastroenterol ; 22(45): 10071-10076, 2016 Dec 07.
Article in English | MEDLINE | ID: mdl-28018115

ABSTRACT

Commercial dietary supplements are marketed as a panacea for the morbidly obese seeking sustainable weight-loss. Unfortunately, many claims cited by supplements are unsupported and inadequately regulated. Most concerning, however, are the associated harmful side effects, often unrecognized by consumers. Garcinia cambogia extract and Garcinia cambogia containing products are some of the most popular dietary supplements currently marketed for weight loss. Here, we report the first known case of fulminant hepatic failure associated with this dietary supplement. One active ingredient in this supplement is hydroxycitric acid, an active ingredient also found in weight-loss supplements banned by the Food and Drug Administration in 2009 for hepatotoxicity. Heightened awareness of the dangers of dietary supplements such as Garcinia cambogia is imperative to prevent hepatoxicity and potential fulminant hepatic failure in additional patients.


Subject(s)
Anti-Obesity Agents/adverse effects , Chemical and Drug Induced Liver Injury/etiology , Citrates/adverse effects , Dietary Supplements/adverse effects , Garcinia cambogia , Liver Failure, Acute/chemically induced , Liver Transplantation , Plant Extracts/adverse effects , Adult , Chemical and Drug Induced Liver Injury/surgery , Humans , Liver Failure, Acute/surgery , Male
SELECTION OF CITATIONS
SEARCH DETAIL